Prophylactic nasal continuous positive airways pressure in newborn of 28-31 weeks gestation: Multicentre randomised controlled clinical trial

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 89, Issue 5, 2004, Pages

  Sandri, F ^a,b   Ancora, G ^b   Lanzoni, A ^b   Tagliabue, P ^c   Colnaghi, M ^d   Ventura, M L ^c   Rinaldi, M ^e   Mondello, I ^f   Gancia, P ^g   Salvioli, G P ^b   Orzalesi, M ^h   Mosca, F ^d  

^a Istituto Clinico di Pediatria Preventiva e Neonatologia   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c SAN GERARDO HOSPITAL   (Italy)

^d ICP   (Italy)

^e OSPEDALI RIUNITI   (Italy)

^f BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

^g FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^h BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID; SURFACTANT;

ARTICLE; ARTIFICIAL VENTILATION; BIRTH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY ROOM; FEMALE; GESTATIONAL AGE; HEALTH STATUS; HUMAN; INTUBATION; ITALY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; NEWBORN INTENSIVE CARE; OXYGEN CONSUMPTION; OXYGEN SATURATION; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRANSCUTANEOUS OXYGEN MONITORING;

CONTINUOUS POSITIVE AIRWAY PRESSURE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTENSIVE CARE, NEONATAL; MALE; OXYGEN; PARTIAL PRESSURE; PULMONARY SURFACTANTS; REGRESSION ANALYSIS; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 4444297204     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/adc.2003.037010     Document Type: Article

References (35)

1. Gregory GA, Kittermann JA, Phibbs RH, et al. Treatment of the idiopathic respiratory distress syndrome with continuous positive airway pressure. N Engl J Med 1971;284:1333-40.
2. Caliumi Pellegrini G, Agostino R, Orzalesi M, et al. Twin nasal canula for the administration of continuous positive pressure to newborn infants. Arch Dis Child 1974;49:228-30.
3. Kattwinkel J, Fleming D, Cha CC, et al. A device for the administration of continuous positive airway pressure by the nasal route. Pediatrics 1973;52:131-4.
4. Kamper J, Ringsted C. Early treatment of idiopathic respiratory distress syndrome using binasal continuous positive airway pressure. Acta Paediatr Scand 1990;79:581-6.
5. Verder H, Robertson B, Greisen G, et al. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. N Engl J Med 1994;331:1051-5.
6. Jonsson B, Katz-Salamon M, Faxelius G, et al. Neonatal care of very low birth weight infants in special care units and neonatal intensive care units in Stockholm. Early nasal continuous positive airway pressure versus mechanical ventilation: gains and losses. Acta Paediatr Suppl 1997;419:4-10.
7. Gittermann MK, Fusch C, Gittermann AR, et al. Early nasal continuous positive airway pressure treatment reduces the need for intubation in very low birth weight infonts. Eur J Pediatr 1997;156:384-8.
8. Pedersen JE, Nielsen K. Oropharyngeal and esophageal pressure during mono-and binasal CPAP in neonates. Acta Paediatr 1994;83:143-9.
9. Klausner JF, Lee AY, Hutchinson AA. Decreased imposed work with a new nasal continuous positive airway pressure device. Pediatr Pulmonol 1996;22:188-94.
10. Kavvadia V, Greenough A, Dimitriou G. Effect on lung function of continuous positive airway pressure administered either by infant flow driver or a single nasal prong. Eur J Pediatr 2000;159:289-92.
11. Courtney SE, Pyon KH, Saslow JG, et al. Lung recruitment and breathing pattern during variable versus continuous positive airway pressure in premature infants. An evaluation of three devices. Pediatrics 2001;197:304-8.
12. Pandit PB, Courtney SE, Pyon KH, et al. Work of breathing during constant and variable flow nasal continuous positive airway pressure in preterm neonates. Pediatrics 2001;108:682-5.
13. Subramaniam P, Henderson-Smart DJ, Davis PG. Prophylactic nasal continuous positive airways pressure for preventing morbidity and mortality in very preterm infants. The Cochrane Neonatal Collaborative Review Group, 2002.
14. Morley C. Continuous distending pressure. Arch Dis Child Fetal Neonatal Ed 1999;81:F152-6.
15. Kattwinkel J, Niermeyer S, Nadkarni V, et al. An advisory statement from the pediatric working group of the linternational Liaison Committee on Resuscitation. Pediatrics 1999;103:e56.
16. Bomsel F. Radiologic study of hyaline membrane disease: 110 cases. J Radiol Elecrol Med Nucl 1970;51:259-68.
17. Anand KJ, Barton BA, McIntosh N, et al. Analgesia and sedation in preterm neonates who require ventilatory support: results from the NOPAIN trial. Neonatal Outcome and Prolonged Analgesia in Neonates. Arch Pediatr Adolesc Med 1999;153:331-8.
18. Varvarigou A, Bardin CL, Beharry K, et al. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. JAMA 1996;275:539-44.
19. Volpe JJ. Neurology of the newborn, 3rd ed. Philadelphia: WB Saunders, 1995:403-63.
20. De Vries LS, Eken P, Dubowitz LMS. The spectrum of leukomalacia using cranial ultrasound. Behav Brain Res 1992;49:1-6.
21. International Neonatal Network. The CRIB (Clinical Risk Index for Babies) score: a tool for assessing initial neonatal risk and comparing performance of neonatal intensive care units. Lancet 1993;342:193-8.
22. De Caurcy-Wheeler RHB, Wolfe CDA, Fitzgerald A, et al. Use of the CRIB (Clinical Risk Index for Babies) score in prediction of neonatal mortality and morbidity. Arch Dis Child Fetal Neonatal Ed 1995;73:F32-6.
23. NIH. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development Panel on the effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA 1995;273:413-18.
24. Soll RF, Blanco F. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. The Cochrane Neonatal Collaborative Review Group, 2001.
25. American Academy of Pediatrics. Committee on fetus and newborn. Surfactant replacement therapy for respiratory distress syndrome. Pediatrics 1999;103:684-5.
26. Soll RF. Multiple versus single dose natural surfactant extract for severe neonatal respiratory distress syndrome. The Cochrane Neonatal Collaborative Review Group, 1999.
27. Yost CC, Soll RF. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. The Cochrane Neonatal Collaborative Review Group, 1999.
28. Soll RF, Morley CJ. Prophylactic surfactant vs treatment with surfactant. The Cochrane Neonatal Collaborative Review Group, 1999.
29. Jacobsen T, Gronvall J, Petersen S, et al. "Minitouch" treatment of very low-birth-weight infants. Acta Paediatr 1993;82:934-8.
30. Verder H, Albertsen P, Ebbesen F, et al. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation. Pediatrics 1999;103:e24.
31. Han VKM, Beverley DW, Clarson C, et al. Randomized controlled trial of very early continuous distending pressure in the management of preterm infants. Early Hum Dev 1987;15:21-32.
32. Poets CF, Southall DP. Noninvasive monitoring of oxygenation in infonts and children: practical considerations and areas or concern. Pediatrics 1994;93:737-46.
33. Paky F, Koeck CM. Pulse oximetry in ventilated preterm newborns: reliability of detection of hyperoxaemia and hypoxaemia, and feasibility of alarm settings. Acta Paediatr 1995;84:613-16.
34. Blennow M, Jonsson B, Dahlstrom A, et al. Lung function in premature infants can be improved. Surfactant therapy and CPAP reduce the need of respiratory support. Lakartidningen 1999;96:1571-6.
35. Stevenson DK, Verter J, Fanaroff AA, et al. Sex differences in outcomes of very low birthweight infants: the newborn male disadvantage. Arch Dis Child Fetal Neonatal Ed 2000;83:F182-5.